{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:55:28Z","timestamp":1767772528749,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["PROGRES Q40-15"],"award-info":[{"award-number":["PROGRES Q40-15"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Optimal therapy for colorectal carcinoma (CRC), a frequently diagnosed malignancy, does not exist. Some of colicins and microcins, ribosomally synthesized\u00a0peptides by gramnegative bacteria, have shown significant biological activity specifically against different cancer cells in vitro and in vivo conditions. The aim of this prospective study was to evaluate natural colicin and microcin production by large intestinal mucosal bacteria in each stage of colorectal neoplasia and in those with a history of colorectal neoplasia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 21 patients with non-advanced adenoma (non-a-A; 16\/21 with current and 5\/21 with history of non-a-A), 20 patients with advanced colorectal adenoma (a-A; 11\/20 with current and 9\/20 with history of a-A), 22 individuals with CRC (9\/22 with current and 13\/22 with history of CRC) and 20 controls were enrolled. Mucosal biopsies from the caecum, transverse colon and the rectum were taken during colonoscopy in each individual. Microbiological culture followed. Production of colicins and microcins was evaluated by PCR methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 239 mucosal biopsies were taken. Production of colicins and microcins was significantly more frequent in individuals with non-a-A, a-A and CRC compared to controls. No significant difference in colicin and microcin production was found between patients with current and previous non-a-A, a-A and CRC. Significantly more frequent production of colicins was observed in men compared to women at the stage of colorectal carcinoma. A later onset of increased production of microcins during the adenoma-carcinoma sequence has been observed in males compared to females.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Strains isolated from large intestinal mucosa in patients with colorectal neoplasia produce colicins and microcins more frequently compared to controls. Bacteriocin production does not differ between patients with current and previous colorectal neoplasia. Fundamental differences in bacteriocin production have been confirmed between males and females.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-020-6512-5","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T15:03:27Z","timestamp":1579187007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6937-309X","authenticated-orcid":false,"given":"Darina","family":"Kohoutova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslava","family":"Forstlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Moravkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Cyrany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Bosak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Smajs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Rejchrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bures","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"issue":"8","key":"6512_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J. Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018. https:\/\/doi.org\/10.1002\/ijc.31937.","journal-title":"International Journal of Cancer"},{"key":"6512_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fphar.2015.00272","volume":"6","author":"S Kaur","year":"2015","unstructured":"Kaur S, Kaur S. Bacteriocins as potential anticancer agents. Front Pharmacol. 2015;6:272.","journal-title":"Front Pharmacol"},{"key":"6512_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bcmd.2006.10.006","volume":"38","author":"LE Lancaster","year":"2007","unstructured":"Lancaster LE, Wintermeyer W, Rodnina MV. Colicins and their potential in cancer treatment. Blood Cells Mol Dis. 2007;38:15\u20138.","journal-title":"Blood Cells Mol Dis"},{"key":"6512_CR4","first-page":"1","volume":"16","author":"NG Vallianou","year":"2019","unstructured":"Vallianou NG, Tzortzatou-Stathopoulou F. Microbiota and cancer: an update. J Chemother. 2019;16:1\u20135.","journal-title":"J Chemother"},{"issue":"8","key":"6512_CR5","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ijc.32003","volume":"145","author":"Danfeng Chen","year":"2018","unstructured":"Chen D, Wu J, Jin D, Wang B, Cao H. Fecal microbiota transplantation in cancer management: current status and perspectives. Int J Cancer. 2018. https:\/\/doi.org\/10.1002\/ijc.32003.","journal-title":"International Journal of Cancer"},{"key":"6512_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bpg.2003.10.003","volume":"18","author":"PM Heavey","year":"2004","unstructured":"Heavey PM, Rowland IR. Microbial-gut interactions in health and disease. Gastrointestinal cancer. Best Pract Res Clin Gastroenterol. 2004;18:323\u201336.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"6512_CR7","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/science.aar6918","volume":"359","author":"L Zitvogel","year":"2018","unstructured":"Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science. 2018;359:1366\u201370.","journal-title":"Science."},{"key":"6512_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrc.2017.13","volume":"17","author":"S Roy","year":"2017","unstructured":"Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17:271\u201385.","journal-title":"Nat Rev Cancer"},{"key":"6512_CR9","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.1007\/s00253-018-9420-8","volume":"102","author":"P Baindara","year":"2018","unstructured":"Baindara P, Korpole S, Grover V. Bacteriocins: perspective for the development of novel anticancer drugs. Appl Microbiol Biotechnol. 2018;102:10393\u2013408.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"6512_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00248693","volume":"161","author":"V Braun","year":"1994","unstructured":"Braun V, Pilsl H, Gross P. Colicins: structures, modes of action, transfer through membranes, and evolution. Arch Microbiol. 1994;161(3):199\u2013206.","journal-title":"Arch Microbiol"},{"key":"6512_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00203-018-1610-3","volume":"201","author":"AS Vasilchenko","year":"2019","unstructured":"Vasilchenko AS, Valyshev AV. Pore-forming bacteriocins: structural-functional relationships. Arch Microbiol. 2019;201:147\u201354.","journal-title":"Arch Microbiol"},{"key":"6512_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/CMR.00056-05","volume":"19","author":"H Jenssen","year":"2006","unstructured":"Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19:491\u2013511.","journal-title":"Clin Microbiol Rev"},{"key":"6512_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF02931286","volume":"48","author":"J Chumchalov\u00e1","year":"2003","unstructured":"Chumchalov\u00e1 J, Smarda J. Human tumor cells are selectively inhibited by colicins. Folia Microbiol (Praha). 2003;48:111\u20135.","journal-title":"Folia Microbiol (Praha)"},{"key":"6512_CR14","first-page":"4043","volume":"26","author":"H Tsugu","year":"2006","unstructured":"Tsugu H, Onishi H, Fukushima T, Lee S. Anti-tumor activity of de novo designed small globular protein (SGP) in vivo. Anticancer Res. 2006;26:4043\u20136.","journal-title":"Anticancer Res"},{"issue":"4","key":"6512_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/COC.0b013e31815e456d","volume":"31","author":"G Cornut","year":"2008","unstructured":"Cornut G, Fortin C, Souli\u00e8res D. Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin Oncol. 2008;31(4):399\u2013404.","journal-title":"Am J Clin Oncol"},{"key":"6512_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/PAS.0b013e31826cf50f","volume":"37","author":"D Mahajan","year":"2013","unstructured":"Mahajan D, Downs-Kelly E, Liu X, Pai RK, Patil DT, Rybicki L, et al. Reproducibility of the villous component and high-grade dysplasia in colorectal adenomas <1 cm: implications for endoscopic surveillance. Am J Surg Pathol. 2013;37:427\u201333.","journal-title":"Am J Surg Pathol"},{"key":"6512_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12879-014-0733-7","volume":"14","author":"D Kohoutova","year":"2014","unstructured":"Kohoutova D, Smajs D, Moravkova P, Cyrany J, Moravkova M, Forstlova M, Cihak M, et al. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia. BMC Infect Dis. 2014;14:733.","journal-title":"BMC Infect Dis"},{"key":"6512_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3748\/wjg.v17.i5.609","volume":"17","author":"J Bures","year":"2011","unstructured":"Bures J, Smajs D, Kvetina J, Forstl M, Smarda J, Kohoutova D, et al. Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle. World J Gastroenterol. 2011;17:609\u201317.","journal-title":"World J Gastroenterol"},{"key":"6512_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1471-2180-10-288","volume":"10","author":"D Smajs","year":"2010","unstructured":"Smajs D, Micenkova L, Smarda J, Vrba M, Sevc\u00edkova A, Valisova Z, et al. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor. BMC Microbiol. 2010;10:288.","journal-title":"BMC Microbiol"},{"key":"6512_CR20","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1128\/JB.183.13.3949-3957.2001","volume":"183","author":"D Smajs","year":"2001","unstructured":"Smajs D, Weinstock GM. Genetic organization of plasmid ColJs, encoding colicin Js activity, immunity, and release genes. J Bacteriol. 2001;183:3949\u201357.","journal-title":"J Bacteriol"},{"key":"6512_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/BF02816372","volume":"43","author":"J Smarda","year":"1998","unstructured":"Smarda J, Smajs D. Colicins - - exocellular lethal proteins of Escherichia coli. Folia Microbiol (Praha). 1998;43:563\u201382.","journal-title":"Folia Microbiol (Praha)"},{"key":"6512_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1128\/MMBR.00036-06","volume":"71","author":"E Cascales","year":"2007","unstructured":"Cascales E, Buchanan SK, Duch\u00e9 D, Kleanthous C, Lloub\u00e8s R, Postle K, et al. Colicin biology. Microbiol Mol Biol Rev. 2007;71:158\u2013229.","journal-title":"Microbiol Mol Biol Rev"},{"key":"6512_CR23","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1074\/jbc.M808504200","volume":"284","author":"T Arnold","year":"2009","unstructured":"Arnold T, Zeth K, Linke D. Structure and function of colicin S4, a colicin with a duplicated receptor-binding domain. J Biol Chem. 2009;284:6403\u201313.","journal-title":"J Biol Chem"},{"issue":"Pt 7","key":"6512_CR24","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1099\/13500872-142-7-1569","volume":"142","author":"R James","year":"1996","unstructured":"James R, Kleanthous C, Moore GR. The biology of E colicins: paradigms and paradoxes. Microbiology. 1996;142(Pt 7):1569\u201380.","journal-title":"Microbiology."},{"key":"6512_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4419-6327-7_7","volume":"677","author":"H Ridley","year":"2010","unstructured":"Ridley H, Johnson CL, Lakey JH. Interfacial interactions of pore-forming colicins. Adv Exp Med Biol. 2010;677:81\u201390.","journal-title":"Adv Exp Med Biol"},{"key":"6512_CR26","doi-asserted-by":"publisher","first-page":"e96549","DOI":"10.1371\/journal.pone.0096549","volume":"9","author":"L Mora","year":"2014","unstructured":"Mora L, de Zamaroczy M. In vivo processing of DNase colicins E2 and E7 is required for their import into the cytoplasm of target cells. PLoS One. 2014;9:e96549.","journal-title":"PLoS One"},{"key":"6512_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0300-9084(02)01451-7","volume":"84","author":"OO Kolade","year":"2002","unstructured":"Kolade OO, Carr SB, K\u00fchlmann UC, Pommer A, Kleanthous C, Bouchcinsky CA, et al. Structural aspects of the inhibition of DNase and rRNase colicins by their immunity proteins. Biochimie. 2002;84:439\u201346.","journal-title":"Biochimie."},{"key":"6512_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1128\/JB.01206-10","volume":"193","author":"S Helbig","year":"2011","unstructured":"Helbig S, Braun V. Mapping functional domains of colicin M. J Bacteriol. 2011;193:815\u201321.","journal-title":"J Bacteriol"},{"key":"6512_CR29","first-page":"11","volume":"47","author":"J Smarda","year":"2001","unstructured":"Smarda J, Fialova M, Smarda J Jr. Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts. Folia Biol (Praha). 2001;47:11\u20133.","journal-title":"Folia Biol (Praha)"},{"key":"6512_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/BF02876680","volume":"23","author":"J Smarda","year":"1978","unstructured":"Smarda J, Smarda J, Obdrz\u00e1lek V, T\u00e1borsk\u00fd I, Mach J. The cytotoxic and cytocidal effect of colicin E3 on mammalian tissue cells. Folia Microbiol (Praha). 1978;23:272\u20137.","journal-title":"Folia Microbiol (Praha)"},{"key":"6512_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/BF01964380","volume":"35","author":"J Fuska","year":"1979","unstructured":"Fuska J, Fuskov\u00e1 A, Smarda J, Mach J. Effect of colicin E3 on leukemia cells P388 in vitro. Experientia. 1979;35:406\u20137.","journal-title":"Experientia."},{"key":"6512_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2180-14-109","volume":"14","author":"L Micenkov\u00e1","year":"2014","unstructured":"Micenkov\u00e1 L, \u0160taudov\u00e1 B, Bos\u00e1k J, Mikalov\u00e1 L, Littnerov\u00e1 S, Vrba M, et al. Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains. BMC Microbiol. 2014;14:109.","journal-title":"BMC Microbiol"},{"key":"6512_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/mc.22146","volume":"54","author":"I Koneczny","year":"2015","unstructured":"Koneczny I, Schulenburg A, Hudec X, Kn\u00f6fler M, Holzmann K, Piazza G, et al. Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cells. Mol Carcinog. 2015;54:789\u201399.","journal-title":"Mol Carcinog"},{"key":"6512_CR34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000104748","volume":"13","author":"S Duquesne","year":"2007","unstructured":"Duquesne S, Petit V, Peduzzi J, Rebuffat S. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from Enterobacteria. J Mol Microbiol Biotechnol. 2007;13:200\u20139.","journal-title":"J Mol Microbiol Biotechnol"},{"key":"6512_CR35","doi-asserted-by":"publisher","first-page":"e33351","DOI":"10.1371\/journal.pone.0033351","volume":"7","author":"A Zsch\u00fcttig","year":"2012","unstructured":"Zsch\u00fcttig A, Zimmermann K, Blom J, Goesmann A, P\u00f6hlmann C, Gunzer F. Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3\/10. PLoS One. 2012;7:e33351.","journal-title":"PLoS One"},{"key":"6512_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0014-5793(93)80096-D","volume":"321","author":"R Lagos","year":"1993","unstructured":"Lagos R, Wilkens M, Vergara C, Cecchi X, Monasterio O. Microcin E492 forms ion channels in phospholipid bilayer membrane. FEBS Lett. 1993;321:145\u20138.","journal-title":"FEBS Lett"},{"key":"6512_CR37","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1073\/pnas.052709699","volume":"99","author":"C Hetz","year":"2002","unstructured":"Hetz C, Bono MR, Barros LF, Lagos R. Microcin E492, a channel forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines. Proc Natl Acad Sci U S A. 2002;99:2696\u2013701.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6512_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/138920109787048643","volume":"10","author":"R Lagos","year":"2009","unstructured":"Lagos R, Tello M, Mercado G, Garc\u00eda V, Monasterio O. Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. Curr Pharm Biotechnol. 2009;10:74\u201385.","journal-title":"Curr Pharm Biotechnol"},{"issue":"9179","key":"6512_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","volume":"354","author":"BJ Rembacken","year":"1999","unstructured":"Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999;354(9179):635\u20139.","journal-title":"Lancet"},{"key":"6512_CR40","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1158\/1078-0432.CCR-07-4254","volume":"14","author":"P Brader","year":"2009","unstructured":"Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, Burnazi EM, et al. Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin Cancer Res. 2009;14:2295\u2013302.","journal-title":"Clin Cancer Res"},{"key":"6512_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/lam.12884","volume":"67","author":"IL Maslennikova","year":"2018","unstructured":"Maslennikova IL, Kuznetsova MV, Toplak N, Nekrasova IV, \u017dgur Bertok D, Star\u010di\u010d EM. Estimation of the bacteriocin ColE7 conjugation-based \"kill\" - \"anti-kill\" antimicrobial system by real-time PCR, fluorescence staining and bioluminescence assays. Lett Appl Microbiol. 2018;67:47\u201353.","journal-title":"Lett Appl Microbiol"},{"key":"6512_CR42","first-page":"233","volume":"33","author":"J Bures","year":"1986","unstructured":"Bures J, Hor\u00e1k V, Fixa B, Kom\u00e1rkov\u00e1 O, Zaydlar K, Lonsk\u00fd V, et al. Colicinogeny in colorectal cancer. Neoplasma. 1986;33:233\u20137.","journal-title":"Neoplasma."},{"key":"6512_CR43","doi-asserted-by":"publisher","first-page":"e32545","DOI":"10.1371\/journal.pone.0032545","volume":"7","author":"L Harrell","year":"2012","unstructured":"Harrell L, Wang Y, Antonopoulos D, Young V, Lichtenstein L, Huang Y, Hanauer S, Chang E. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS One. 2012;7:e32545.","journal-title":"PLoS One"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6512-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:14:55Z","timestamp":1610669695000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6512-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6512"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6512-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2020,1,16]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients enrolled into the study were adequately informed, supplied and signed an informed consent. The project was approved by the Joint Ethical Committee (Charles University in Praha, Faculty of Medicine at Hradec Kralove & University Teaching Hospital Hradec Kralove) under the number 201107\u2009S54.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"For all data obtained, all personal identification information was removed in compliance with the Czech laws for protection of confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}